An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors (Q38236642)

From Wikidata

Jump to navigation Jump to search

scientific article published on 04 August 2014

Language	Label	Description	Also known as
English	An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors	scientific article published on 04 August 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

2

object named as

U Popat

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

K Adekola

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

S O Ciurea

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

0 references

publication date

4 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

49

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1352-1359

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Stem Cell Transplant for Chronic Myeloid Leukemia in the Imatinib Era

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Philadelphia chromosome-negative myeloproliferative disorders: biology and treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Ruxolitinib: an oral Janus kinase 1 and Janus kinase 2 inhibitor in the management of myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

How I treat myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Management of myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Outcome of transplantation for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Current status of allogeneic HST for chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Diagnosis and management of chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.176

21 January 2018

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Tra

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2014.176

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Dimensions Publication ID

0 references

release_5zroh7ybijetdp6e74hjpqloem

1 reference

https://api.fatcat.wiki/v0/release/5zroh7ybijetdp6e74hjpqloem

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25089599%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38236642&oldid=2201448672"